FireEye Inc (FEYE), Skechers USA Inc (SKX), and More: Here’s What Analysts Had To Say About These Trending Stocks

Page 2 of 2

Paypal Holdings Inc (NASDAQ:PYPL) received the thumbs up from Stifel analyst Scott Devitt, who upgraded the stock to ‘Buy’ from ‘Hold’ and set a $49 price target. Devitt liked Paypal’s ‘solid’ third-quarter results and thinks the risk associated with the company’s execution has dropped substantially. Devitt also thinks Paypal can offer ‘stable, consistent, and robust’ growth for the years to come. A total of 84 funds tracked by us owned shares of Paypal Holdings Inc (NASDAQ:PYPL) at the end of June, down by three funds from the previous quarter.

Follow Paypal Holdings Inc. (NASDAQ:PYPL)

Although he lowered his price target on athenahealth, Inc (NASDAQ:ATHN) to $164 per share from $174 due to the company’s third quarter results, Sean Wieland of Piper Jaffray nevertheless has an ‘Overweight’ rating on the stock. Wieland thinks shares are a buy given the ‘low watermark multiple’. Wieland also noted athenahealth’s valuation is similar to the valuation of Cerner, something that could offer support to shares. The number of funds from our database with holdings in athenahealth, Inc (NASDAQ:ATHN) fell by four quarter-over-quarter to 20 at the end of June.

Follow Athenahealth Inc (NASDAQ:ATHN)

Wendy Nicholson of Citi gave Avon Products, Inc. (NYSE:AVP) her nod of approval on Friday after she raised her price target to $8 per share from $6 and reiterated her ‘Buy’ recommendation. Nicholson thinks shares are more ‘investable’ given that the company has refinanced some of its debt, which has reduced bankruptcy concerns. Nicholson also considers the Cerberus investment has increased shareholder confidence in the management team. At the end of June, 25 funds tracked by Insider Monkey owned $215.34 million worth of Avon Products, Inc. (NYSE:AVP)’s stock, which accounted for 13.00% of the float on June 30, versus 28 and $256.7 million, respectively, on March 31.

Follow Avon Products Inc (NYSE:AVP)

Disclosure: None

Page 2 of 2